Philipp J Jost

23PUBLICATIONS
135CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersHuman rights and justice issues (excl. law)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg

|Nov 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

|Aug 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.

Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat

|Jun 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Heikki Joensuu, Annette Reichardt, Mikael Eriksson

|Nov 20, 2023
Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.

Jakob M Riedl, Florian Moik, Tamara Esterl

|Apr 04, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.

Heikki Joensuu, Eva Wardelmann, Mikael Eriksson

Pageof 4

Frequent Collaborators

4 joint publications

Thomas Kaufmann

4 joint publications

Deepti Agrawal

3 joint publications

Sebastian Bauer

3 joint publications

Stefan Fröhling